Loading...

Walgreens Boots Alliance, Inc. Peer Comparison

Metric Value Ranking
Market Cap $8.1 Billion 1/9 WBA
$8.1B
HITI
$212.8M
PETS
$85.3M
YI
$62.0M
RAD
$36.9M
MEDS
$13.3M
MDVL
$2.9M
LFLY
$799,292
BIMI
$0
Gross Margin 17% 6/9 LFLY
89%
MDVL
44%
PETS
32%
HITI
26%
RAD
19%
WBA
17%
YI
6%
BIMI
5%
MEDS
-4%
Profit Margin -1% 3/9 PETS
4%
YI
0%
WBA
-1%
HITI
-3%
LFLY
-14%
RAD
-18%
BIMI
-100%
MEDS
-100%
MDVL
-100%
EBITDA margin -1% 4/9 PETS
4%
HITI
3%
YI
0%
WBA
-1%
RAD
-6%
LFLY
-7%
BIMI
-127%
MDVL
-1357%
MEDS
-7954%
Quarterly Revenue $39.5 Billion 1/9 WBA
$39.5B
RAD
$5.6B
YI
$829.6M
HITI
$104.0M
PETS
$59.6M
LFLY
$8.4M
BIMI
$2.5M
MDVL
$405,000
MEDS
$18,699
Quarterly Earnings -$265.0 Million 8/9 PETS
$2.3M
LFLY
-$1.1M
MEDS
-$1.8M
BIMI
-$3.1M
HITI
-$3.5M
YI
-$3.9M
MDVL
-$5.8M
WBA
-$265.0M
RAD
-$1.0B
Quarterly Free Cash Flow -$424.0 Million 8/9 YI
$25.3M
PETS
$6.1M
HITI
$5.7M
MEDS
$4.2M
LFLY
-$345,000
BIMI
-$2.1M
MDVL
-$5.3M
WBA
-$424.0M
RAD
-$949.9M
Trailing 4 Quarters Revenue $181.7 Billion 1/9 WBA
$181.7B
RAD
$23.5B
YI
$3.4B
HITI
$392.7M
PETS
$306.8M
LFLY
$35.9M
MDVL
$23.8M
BIMI
$5.8M
MEDS
$4.4M
Trailing 4 Quarters Earnings -$8.8 Billion 9/9 WBA
$39.5B
RAD
$5.6B
YI
$829.6M
HITI
$104.0M
PETS
$59.6M
LFLY
$8.4M
BIMI
$2.5M
MDVL
$405,000
MEDS
$18,699
Quarterly Earnings Growth -296% 9/9 PETS
3423%
HITI
85%
YI
82%
MDVL
51%
LFLY
48%
BIMI
16%
MEDS
7%
RAD
-208%
WBA
-296%
Annual Earnings Growth -1355% 9/9 HITI
89%
PETS
65%
LFLY
19%
BIMI
13%
MDVL
9%
YI
4%
RAD
1%
MEDS
-1080%
WBA
-1355%
Quarterly Revenue Growth 7% 2/9 HITI
9%
WBA
7%
YI
-2%
RAD
-4%
PETS
-16%
LFLY
-21%
BIMI
-66%
MDVL
-96%
MEDS
-99%
Annual Revenue Growth -21% 5/9 YI
4%
HITI
4%
PETS
0%
LFLY
-16%
WBA
-21%
MDVL
-38%
RAD
-44%
MEDS
-51%
BIMI
-74%
Cash On Hand $859.0 Million 1/9 WBA
$859.0M
YI
$122.6M
RAD
$92.9M
PETS
$52.0M
HITI
$35.5M
LFLY
$13.6M
MEDS
$7.7M
BIMI
$994,131
MDVL
-$0
Short Term Debt $2.8 Billion 2/9 RAD
$4.2B
WBA
$2.8B
YI
$38.8M
HITI
$26.8M
BIMI
$2.0M
PETS
$446,000
MDVL
$208,000
MEDS
$32,607
LFLY
-$0
Long Term Debt $27.9 Billion 1/9 WBA
$27.9B
RAD
$2.4B
HITI
$29.3M
YI
$14.7M
BIMI
$2.5M
MDVL
$2.1M
PETS
$768,000
MEDS
$160,996
LFLY
$0
PE -1.00 1/9 WBA
-1.00
RAD
-1.00
PETS
-1.00
YI
-1.00
BIMI
-1.00
MEDS
-1.00
MDVL
-1.00
HITI
-1.00
LFLY
-1.00
PS 0.04 6/9 MEDS
3.00
HITI
0.72
PETS
0.28
MDVL
0.12
YI
0.08
WBA
0.04
LFLY
0.02
RAD
0.00
BIMI
0.00
PB 0.72 5/9 HITI
1.94
MEDS
1.13
PETS
0.88
YI
0.87
WBA
0.72
RAD
0.00
BIMI
0.00
MDVL
0.00
LFLY
0.00
PC 9.42 1/9 WBA
9.42
HITI
5.99
MEDS
1.72
PETS
1.64
YI
0.51
RAD
0.40
LFLY
0.06
BIMI
0.00
MDVL
-1.00
Liabilities to Equity 6.02 1/9 WBA
6.02
BIMI
2.86
HITI
0.70
PETS
0.51
MDVL
0.30
MEDS
0.26
RAD
0.00
YI
0.00
LFLY
0.00
ROA -0.11 4/9 PETS
-1%
HITI
-1%
YI
-2%
WBA
-11%
RAD
-23%
LFLY
-27%
BIMI
-40%
MDVL
-100%
MEDS
-172%
ROE -0.79 6/9 RAD
83%
LFLY
36%
YI
9%
PETS
-1%
HITI
-2%
WBA
-79%
BIMI
-161%
MDVL
-200%
MEDS
-216%
Current Ratio 1.17 5/9 MEDS
4.85
PETS
2.94
HITI
2.45
BIMI
1.41
WBA
1.17
YI
1.11
RAD
0.78
LFLY
0.58
MDVL
0.00
Quick Ratio 0.02 7/9 WBA
-1.00
RAD
-1.00
PETS
-1.00
YI
-1.00
BIMI
-1.00
MEDS
-1.00
MDVL
-1.00
HITI
-1.00
LFLY
-1.00
Long Term Debt to Equity 2.50 1/9 WBA}
2.50
BIMI}
0.28
HITI}
0.27
MDVL}
0.09
PETS}
0.01
MEDS}
0.01
LFLY}
0.00
YI}
-0.10
RAD}
-1.21
Debt to Equity 2.75 1/9 WBA
2.75
HITI
0.52
BIMI
0.51
MDVL
0.10
MEDS
0.02
PETS
0.01
LFLY
0.00
YI
-0.37
RAD
-3.35
Burn Rate 0.41 5/9 LFLY
11.91
YI
10.94
MEDS
4.18
HITI
3.38
WBA
0.41
BIMI
0.27
RAD
0.04
MDVL
0.00
PETS
-23.83
Cash to Cap 0.11 7/9 LFLY
16.97
RAD
2.52
YI
1.98
PETS
0.61
MEDS
0.58
HITI
0.17
WBA
0.11
MDVL
0.00
BIMI
CCR 1.60 2/9 PETS
2.63
WBA
1.60
RAD
0.93
MDVL
0.92
BIMI
0.67
LFLY
0.30
HITI
-1.63
MEDS
-2.30
YI
-6.42
EV to EBITDA -160.75 9/9 HITI}
43.01
LFLY}
23.34
PETS}
13.36
MDVL}
-0.94
BIMI}
-1.08
MEDS}
-3.87
RAD}
-17.98
YI}
-65.52
WBA}
-160.75
EV to Revenue 0.21 6/9 MEDS
1.30
BIMI
0.59
HITI
0.48
RAD
0.28
MDVL
0.22
WBA
0.21
PETS
0.11
YI
-0.08
LFLY
-0.36